‘Browning’ the cardiac and peri-vascular adipose tissues to modulate cardiovascular risk

International Journal of Cardiology

Volumn 228, Issue , 2017, Pages 265-274

  Aldiss, Peter ^a   Davies, Graeme ^a   Woods, Rachel ^a   Budge, Helen ^a   Sacks, Harold S ^b   Symonds, Michael E ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brown adipose tissue; CVD; Epicardial adipose tissue; Perivascular adipose tissue

Indexed keywords

CONJUGATED LINOLEIC ACID; DOCOSAHEXAENOIC ACID; EXENDIN 4; FATTY ACID; FIBROBLAST GROWTH FACTOR 21; ICOSAPENTAENOIC ACID; IRISIN; LIRAGLUTIDE; METEORIN 1; MIRABEGRON; NATRIURETIC FACTOR; NITRATE; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOGENESIS; ATHEROSCLEROTIC PLAQUE; BROWN ADIPOSE TISSUE; BROWNING; CARDIAC MUSCLE CELL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLD EXPOSURE; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; EPICARDIAL FAT; EXERCISE; FATTY ACID METABOLISM; GENE EXPRESSION; HUMAN; INTRAMYOCARDIAL ADIPOSE TISSUE; LIPID HOMEOSTASIS; LIPID STORAGE; LIPOGENESIS; NONHUMAN; OBESITY; PARACARDIAL ADIPOSE TISSUE; PERICARDIAL FAT; PERIVASCULAR ADIPOSE TISSUE; PREGNANCY; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; THERMOGENESIS; TISSUE DIFFERENTIATION; UPREGULATION; WHITE ADIPOSE TISSUE; BEIGE ADIPOSE TISSUE; BODY MASS; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; FEMALE; INTRAABDOMINAL FAT; MALE; METABOLISM; PHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT;

ADIPOSE TISSUE, BEIGE; ADIPOSE TISSUE, BROWN; ADIPOSITY; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; OBESITY; PROGNOSIS; RISK ASSESSMENT;

EID: 84995901385     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.074     Document Type: Review

References (172)

1. [1] Hubert, H.B., Feinleib, M., McNamara, P.M., Castelli, W.P., Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 (1983), 968–977.
2. [2] Hughes-Austin, J.M., Larsen, B.A., Allison, M.A., Visceral adipose tissue and cardiovascular disease risk. Curr. Cardiovasc. Risk Rep. 7 (2013), 95–101, 10.1007/s12170-013-0298-9.
3. [3] Maresca, F., et al. Adipokines, vascular wall, and cardiovascular disease: a focused overview of the role of adipokines in the pathophysiology of cardiovascular disease. Angiology 66 (2015), 8–24, 10.1177/0003319713520463.
4. [4] Nakamura, K., Fuster, J.J., Walsh, K., Adipokines: a link between obesity and cardiovascular disease. J. Cardiol. 63 (2014), 250–259, 10.1016/j.jjcc.2013.11.006.
5. [5] Cannon, B., Nedergaard, J., Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 (2004), 277–359.
6. [6] Cypess, A.M., et al. Identification and importance of brown adipose tissue in adult humans. N. Engl. J. Med. 360 (2009), 1509–1517, 10.1056/NEJMoa0810780.
7. [7] Takx, R., et al. Supraclavicular Brown adipose tissue FDG uptake and cardiovascular disease. J. Nucl. Med., 2016, 10.2967/jnumed.115.166025.
8. [8] van Marken Lichtenbelt, W.D., et al. Cold-activated brown adipose tissue in healthy men. N. Engl. J. Med. 360 (2009), 1500–1508, 10.1056/NEJMoa0808718.
9. [9] Iacobellis, G., Local and systemic effects of the multifaceted epicardial adipose tissue depot. Nat. Rev. Endocrinol. 11 (2015), 363–371, 10.1038/nrendo.2015.58.
10. [10] Dey, D., Nakazato, R., Li, D., Berman, D.S., Epicardial and thoracic fat - noninvasive measurement and clinical implications. Cardiovasc. Diagn. Ther. 2 (2012), 85–93, 10.3978/j.issn.2223-3652.2012.04.03.
11. [11] Cheung, L., et al. Human mediastinal adipose tissue displays certain characteristics of brown fat. Nutr. Diabetes, 3, 2013, e66, 10.1038/nutd.2013.6.
12. [12] Yamaguchi, Y., et al. Adipogenesis and epicardial adipose tissue: a novel fate of the epicardium induced by mesenchymal transformation and PPARgamma activation. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 2070–2075, 10.1073/pnas.1417232112.
13. [13] Sacks, H.S., Fain, J.N., Human epicardial adipose tissue: a review. Am. Heart J. 153 (2007), 907–917, 10.1016/j.ahj.2007.03.019.
14. [14] Corradi, D., et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc. Pathol. 13 (2004), 313–316, 10.1016/j.carpath.2004.08.005.
15. [15] Shirani, J., Berezowski, K., Roberts, W.C., Quantitative measurement of normal and excessive (cor adiposum) subepicardial adipose tissue, its clinical significance, and its effect on electrocardiographic QRS voltage. Am. J. Cardiol. 76 (1995), 414–418.
16. [16] Company, J.M., et al. Epicardial fat gene expression after aerobic exercise training in pigs with coronary atherosclerosis: relationship to visceral and subcutaneous fat. J. Appl. Physiol. (1985) 109 (2010), 1904–1912, 10.1152/japplphysiol.00621.2010.
17. [17] Selthofer-Relatic, K., Bosnjak, I., Myocardial fat as a part of cardiac visceral adipose tissue: physiological and pathophysiological view. J. Endocrinol. Investig. 38 (2015), 933–939, 10.1007/s40618-015-0258-y.
18. [18] Zhang, H., et al. Endocardium contributes to cardiac fat. Circ. Res., 2015, 10.1161/CIRCRESAHA.115.307202.
19. [19] Kami, D., Kitani, T., Kawasaki, T., Gojo, S., Cardiac mesenchymal progenitors differentiate into adipocytes via Klf4 and c-Myc. Cell Death Dis., 7, 2016, e2190, 10.1038/cddis.2016.31.
20. [20] Szasz, T., Bomfim, G.F., Webb, R.C., The influence of perivascular adipose tissue on vascular homeostasis. Vasc. Health Risk Manag. 9 (2013), 105–116, 10.2147/VHRM.S33760.
21. [21] Guauque-Olarte, S., et al. The transcriptome of human epicardial, mediastinal and subcutaneous adipose tissues in men with coronary artery disease. PLoS One, 6, 2011, e19908, 10.1371/journal.pone.0019908.
22. [22] Atalar, F., et al. Mediastinal adipose tissue expresses a pathogenic profile of 11 beta-hydroxysteroid dehydrogenase type 1, glucocorticoid receptor, and CD68 in patients with coronary artery disease. Cardiovasc. Pathol. 22 (2013), 183–188, 10.1016/j.carpath.2012.07.006.
23. [23] Atalar, F., et al. The role of mediastinal adipose tissue 11beta-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease. Cardiovasc. Diabetol., 11, 2012, 115, 10.1186/1475-2840-11-115.
24. [24] Szasz, T., Webb, R.C., Perivascular adipose tissue: more than just structural support. Clin. Sci. (Lond.) 122 (2012), 1–12, 10.1042/CS20110151.
25. [25] Nakagawa, K., et al. Leptin causes vasodilation in humans. Hypertens. Res. 25 (2002), 161–165.
26. [26] Matsuda, K., et al. Leptin causes nitric-oxide independent coronary artery vasodilation in humans. Hypertens. Res. 26 (2003), 147–152.
27. [27] Fesus, G., et al. Adiponectin is a novel humoral vasodilator. Cardiovasc. Res. 75 (2007), 719–727, 10.1016/j.cardiores.2007.05.025.
28. [28] Gao, Y.J., Lu, C., Su, L.Y., Sharma, A.M., Lee, R.M., Modulation of vascular function by perivascular adipose tissue: the role of endothelium and hydrogen peroxide. Br. J. Pharmacol. 151 (2007), 323–331, 10.1038/sj.bjp.0707228.
29. [29] Lee, R.M., Lu, C., Su, L.Y., Gao, Y.J., Endothelium-dependent relaxation factor released by perivascular adipose tissue. J. Hypertens. 27 (2009), 782–790, 10.1097/HJH.0b013e328324ed86.
30. [30] Marchington, J.M., Pond, C.M., Site-specific properties of pericardial and epicardial adipose tissue: the effects of insulin and high-fat feeding on lipogenesis and the incorporation of fatty acids in vitro. Int. J. Obes. 14 (1990), 1013–1022.
31. [31] Marchington, J.M., Mattacks, C.A., Pond, C.M., Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp. Biochem. Physiol. B 94 (1989), 225–232.
32. [32] Wisneski, J.A., Gertz, E.W., Neese, R.A., Mayr, M., Myocardial metabolism of free fatty acids. Studies with 14C-labeled substrates in humans. J. Clin. Invest. 79 (1987), 359–366, 10.1172/JCI112820.
33. [33] Sacks, H.S., et al. Adult epicardial fat exhibits beige features. J. Clin. Endocrinol. Metab. 98 (2013), E1448–E1455, 10.1210/jc.2013-1265.
34. [34] Sacks, H.S., et al. Uncoupling protein-1 and related messenger ribonucleic acids in human epicardial and other adipose tissues: epicardial fat functioning as brown fat. J. Clin. Endocrinol. Metab. 94 (2009), 3611–3615, 10.1210/jc.2009-0571.
35. [35] Carriere, A., et al. Browning of white adipose cells by intermediate metabolites: an adaptive mechanism to alleviate redox pressure. Diabetes 63 (2014), 3253–3265, 10.2337/db13-1885.
36. [36] Costa, R.M., et al. H2O2 generated from mitochondrial electron transport chain in thoracic perivascular adipose tissue is crucial for modulation of vascular smooth muscle contraction. Vasc. Pharmacol., 2016, 10.1016/j.vph.2016.05.008.
37. [37] Chechi, K., Blanchard, P.G., Mathieu, P., Deshaies, Y., Richard, D., Brown fat like gene expression in the epicardial fat depot correlates with circulating HDL-cholesterol and triglycerides in patients with coronary artery disease. Int. J. Cardiol. 167 (2013), 2264–2270, 10.1016/j.ijcard.2012.06.008.
38. [38] Sacks, H., Symonds, M.E., Anatomical locations of human brown adipose tissue: functional relevance and implications in obesity and type 2 diabetes. Diabetes 62 (2013), 1783–1790, 10.2337/db12-1430.
39. [39] Ozen, G., Daci, A., Norel, X., Topal, G., Human perivascular adipose tissue dysfunction as a cause of vascular disease: focus on vascular tone and wall remodeling. Eur. J. Pharmacol. 766 (2015), 16–24, 10.1016/j.ejphar.2015.09.012.
40. [40] Omar, A., Chatterjee, T.K., Tang, Y., Hui, D.Y., Weintraub, N.L., Proinflammatory phenotype of perivascular adipocytes. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1631–1636, 10.1161/ATVBAHA.114.303030.
41. [41] Rittig, K., et al. The secretion pattern of perivascular fat cells is different from that of subcutaneous and visceral fat cells. Diabetologia 55 (2012), 1514–1525, 10.1007/s00125-012-2481-9.
42. [42] Schlich, R., et al. VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue. Mediat. Inflamm., 2013, 2013, 982458, 10.1155/2013/982458.
43. [43] Brown, N.K., et al. Perivascular adipose tissue in vascular function and disease: a review of current research and animal models. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1621–1630, 10.1161/ATVBAHA.114.303029.
44. [44] Chang, L., et al. Loss of perivascular adipose tissue on peroxisome proliferator-activated receptor-gamma deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation 126 (2012), 1067–1078, 10.1161/CIRCULATIONAHA.112.104489.
45. [45] Fitzgibbons, T.P., et al. Similarity of mouse perivascular and brown adipose tissues and their resistance to diet-induced inflammation. Am. J. Physiol. Heart Circ. Physiol. 301 (2011), H1425–H1437, 10.1152/ajpheart.00376.2011.
46. [46] Mazur, A., Ostanski, M., Telega, G., Malecka-Tendera, E., Is epicardial fat tissue a marker of metabolic syndrome in obese children?. Atherosclerosis 211 (2010), 596–600, 10.1016/j.atherosclerosis.2010.02.036.
47. [47] Akyol, B., Boyraz, M., Aysoy, C., Relationship of epicardial adipose tissue thickness with early indicators of atherosclerosis and cardiac functional changes in obese adolescents with metabolic syndrome. J. Clin. Res. Pediatr. Endocrinol. 5 (2013), 156–163, 10.4274/Jcrpe.1064.
48. [48] Boyraz, M., et al. Importance of epicardial adipose tissue thickness measurement in obese adolescents, its relationship with carotid intima-media thickness, and echocardiographic findings. Eur. Rev. Med. Pharmacol. Sci. 17 (2013), 3309–3317.
49. [49] Schusterova, I., Leenen, F.H., Jurko, A., Sabol, F., Takacova, J., Epicardial adipose tissue and cardiometabolic risk factors in overweight and obese children and adolescents. Pediatr. Obes. 9 (2014), 63–70, 10.1111/j.2047-6310.2012.00134.x.
50. [50] Iacobellis, G., et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J. Clin. Endocrinol. Metab. 88 (2003), 5163–5168, 10.1210/jc.2003-030698.
51. [51] Iacobellis, G., et al. Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes. Res. 11 (2003), 304–310, 10.1038/oby.2003.45.
52. [52] Iacobellis, G., Leonetti, F., Epicardial adipose tissue and insulin resistance in obese subjects. J. Clin. Endocrinol. Metab. 90 (2005), 6300–6302, 10.1210/jc.2005-1087.
53. [53] Taguchi, R., et al. Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis 157 (2001), 203–209.
54. [54] Maurovich-Horvat, P., et al. Influence of pericoronary adipose tissue on local coronary atherosclerosis as assessed by a novel MDCT volumetric method. Atherosclerosis 219 (2011), 151–157, 10.1016/j.atherosclerosis.2011.06.049.
55. [55] Aydin, A.M., Kayali, A., Poyraz, A.K., Aydin, K., The relationship between coronary artery disease and pericoronary epicardial adipose tissue thickness. J. Int. Med. Res. 43 (2015), 17–25, 10.1177/0300060514558323.
56. [56] Demircelik, M.B., et al. Epicardial adipose tissue and pericoronary fat thickness measured with 64-multidetector computed tomography: potential predictors of the severity of coronary artery disease. Clinics 69 (2014), 388–392, 10.6061/clinics/2014(06)04.
57. [57] McKenney, M.L., et al. Epicardial adipose excision slows the progression of porcine coronary atherosclerosis. J. Cardiothorac. Surg., 9, 2014, 10.1186/1749-8090-9-2.
58. [58] Hyvonen, M.T., Spalding, K.L., Maintenance of white adipose tissue in man. Int. J. Biochem. Cell Biol. 56 (2014), 123–132, 10.1016/j.biocel.2014.09.013.
59. [59] Tchkonia, T., et al. Fat tissue, aging, and cellular senescence. Aging Cell 9 (2010), 667–684, 10.1111/j.1474-9726.2010.00608.x.
60. [60] Wensveen, F.M., Valentic, S., Sestan, M., Turk Wensveen, T., Polic, B., The “big bang” in obese fat: events initiating obesity-induced adipose tissue inflammation. Eur. J. Immunol. 45 (2015), 2446–2456, 10.1002/eji.201545502.
61. [61] Shimizu, I., et al. Vascular rarefaction mediates whitening of brown fat in obesity. J. Clin. Invest. 124 (2014), 2099–2112, 10.1172/JCI71643.
62. [62] Shimizu, I., Walsh, K., The whitening of brown fat and its implications for weight management in obesity. Curr. Obes. Rep. 4 (2015), 224–229, 10.1007/s13679-015-0157-8.
63. [63] Roberts-Toler, C., O'Neill, B.T., Cypess, A.M., Diet-induced obesity causes insulin resistance in mouse brown adipose tissue. Obesity (Silver Spring) 23 (2015), 1765–1770, 10.1002/oby.21134.
64. [64] Ojha, S., Robinson, L., Yazdani, M., Symonds, M.E., Budge, H., Brown adipose tissue genes in pericardial adipose tissue of newborn sheep are downregulated by maternal nutrient restriction in late gestation. Pediatr. Res. 74 (2013), 246–251, 10.1038/pr.2013.107.
65. [65] Ojha, S., Symonds, M.E., Budge, H., Suboptimal maternal nutrition during early-to-mid gestation in the sheep enhances pericardial adiposity in the near-term fetus. Reprod. Fertil. Dev., 2014, 10.1071/RD14007.
66. [66] Dozio, E., et al. Increased reactive oxygen species production in epicardial adipose tissues from coronary artery disease patients is associated with brown-to-white adipocyte trans-differentiation. Int. J. Cardiol. 174 (2014), 413–414, 10.1016/j.ijcard.2014.04.045.
67. [67] McAninch, E.A., et al. Epicardial adipose tissue has a unique transcriptome modified in severe coronary artery disease. Obesity (Silver Spring) 23 (2015), 1267–1278, 10.1002/oby.21059.
68. [68] Kajimura, S., Spiegelman, B.M., Seale, P., Brown and beige fat: physiological roles beyond heat generation. Cell Metab. 22 (2015), 546–559, 10.1016/j.cmet.2015.09.007.
69. [69] Townsend, K., Tseng, Y.H., Brown adipose tissue: recent insights into development, metabolic function and therapeutic potential. Adipocyte 1 (2012), 13–24, 10.4161/adip.18951.
70. [70] Cypess, A.M., et al. Anatomical localization, gene expression profiling and functional characterization of adult human neck brown fat. Nat. Med. 19 (2013), 635–639, 10.1038/nm.3112.
71. [71] Robinson, L., Ojha, S., Symonds, M.E., Budge, H., Body mass index as a determinant of brown adipose tissue function in healthy children. J. Pediatr. 164 (2014), 318–322, e311, 10.1016/j.jpeds.2013.10.005.
72. [72] Symonds, M.E., et al. Thermal imaging to assess age-related changes of skin temperature within the supraclavicular region co-locating with brown adipose tissue in healthy children. J. Pediatr. 161 (2012), 892–898, 10.1016/j.jpeds.2012.04.056.
73. [73] Ouellet, V., et al. Outdoor temperature, age, sex, body mass index, and diabetic status determine the prevalence, mass, and glucose-uptake activity of 18F-FDG-detected BAT in humans. J. Clin. Endocrinol. Metab. 96 (2011), 192–199, 10.1210/jc.2010-0989.
74. [74] Yoneshiro, T., et al. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity (Silver Spring) 19 (2011), 1755–1760, 10.1038/oby.2011.125.
75. [75] Orava, J., et al. Different metabolic responses of human brown adipose tissue to activation by cold and insulin. Cell Metab. 14 (2011), 272–279, 10.1016/j.cmet.2011.06.012.
76. [76] Ouellet, V., et al. Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans. J. Clin. Invest. 122 (2012), 545–552, 10.1172/JCI60433.
77. [77] Chondronikola, M., et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes 63 (2014), 4089–4099, 10.2337/db14-0746.
78. [78] Lee, P., et al. Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans. Diabetes 63 (2014), 3686–3698, 10.2337/db14-0513.
79. [79] Hanssen, M.J., et al. Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med. 21 (2015), 863–865, 10.1038/nm.3891.
80. [80] Bartelt, A., Heeren, J., Adipose tissue browning and metabolic health. Nat. Rev. Endocrinol. 10 (2014), 24–36, 10.1038/nrendo.2013.204.
81. [81] Berbee, J.F., et al. Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development. Nat. Commun., 6, 2015, 6356, 10.1038/ncomms7356.
82. [82] Stanford, K.I., et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J. Clin. Invest. 123 (2013), 215–223, 10.1172/JCI62308.
83. [83] Gunawardana, S.C., Piston, D.W., Insulin-independent reversal of type 1 diabetes in nonobese diabetic mice with brown adipose tissue transplant. Am. J. Physiol. Endocrinol. Metab. 308 (2015), E1043–E1055, 10.1152/ajpendo.00570.2014.
84. [84] Shabalina, I.G., et al. UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic. Cell Rep. 5 (2013), 1196–1203, 10.1016/j.celrep.2013.10.044.
85. [85] Okamatsu-Ogura, Y., et al. Thermogenic ability of uncoupling protein 1 in beige adipocytes in mice. PLoS One, 8, 2013, e84229, 10.1371/journal.pone.0084229.
86. [86] Symonds, M.E., Pope, M., Sharkey, D., Budge, H., Adipose tissue and fetal programming. Diabetologia 55 (2012), 1597–1606, 10.1007/s00125-012-2505-5.
87. [87] Symonds, M.E., Pope, M., Budge, H., Adipose tissue development during early life: novel insights into energy balance from small and large mammals. Proc. Nutr. Soc. 71 (2012), 363–370, 10.1017/S0029665112000584.
88. [88] Bredella, M.A., Fazeli, P.K., Lecka-Czernik, B., Rosen, C.J., Klibanski, A., IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women. Bone 53 (2013), 336–339, 10.1016/j.bone.2012.12.046.
89. [89] Pasanisi, F., et al. Evidence of brown fat activity in constitutional leanness. J. Clin. Endocrinol. Metab. 98 (2013), 1214–1218, 10.1210/jc.2012-2981.
90. [90] Symonds, M.E., Pope, M., Budge, H., The ontogeny of brown adipose tissue. Annu. Rev. Nutr. 35 (2015), 295–320, 10.1146/annurev-nutr-071813-105330.
91. [91] Barker, D.J., Fetal origins of coronary heart disease. Br. Heart J. 69 (1993), 195–196.
92. [92] Zaborska, K.E., Wareing, M., Edwards, G., Austin, C., Loss of anti-contractile effect of perivascular adipose tissue in offspring of obese rats. Int. J. Obes., 2016, 10.1038/ijo.2016.62.
93. [93] Barbatelli, G., et al. The emergence of cold-induced brown adipocytes in mouse white fat depots is determined predominantly by white to brown adipocyte transdifferentiation. Am. J. Physiol. Endocrinol. Metab. 298 (2010), E1244–E1253, 10.1152/ajpendo.00600.2009.
94. [94] Cannon, B., Nedergaard, J., Brown adipose tissue: function and physiological significance. Physiol. Rev. 84 (2004), 277–359, 10.1152/physrev.00015.2003.
95. [95] Dijk, W., et al. ANGPTL4 mediates shuttling of lipid fuel to brown adipose tissue during sustained cold exposure. Elife, 4, 2015, 10.7554/eLife.08428.
96. [96] Bartelt, A., et al. Brown adipose tissue activity controls triglyceride clearance. Nat. Med. 17 (2011), 200–U293, 10.1038/nm.2297.
97. [97] De Lorenzo, F., Mukherjee, M., Kadziola, Z., Sherwood, R., Kakkar, V.V., Central cooling effects in patients with hypercholesterolaemia. Clin. Sci. (Lond.) 95 (1998), 213–217.
98. [98] Healy, J.D., Excess winter mortality in Europe: a cross country analysis identifying key risk factors. J. Epidemiol. Community Health 57 (2003), 784–789.
99. [99] Gonseth, S., Nussle, S., Bovet, P., Panese, F., Wiemels, J.L., Excess winter deaths caused by cardiovascular diseases are associated with both mild winter temperature and socio-economic inequalities in the U.S. Int. J. Cardiol. 187 (2015), 642–644, 10.1016/j.ijcard.2015.03.412.
100. [100] Guest, C., W., K., Woodward, A., Hennessy, K., Kalkstein, L., Skinner, C., McMichael, A.J., Climate and mortality in Australia: retrospective study, 1979–1990, and predicted impacts in five major cities in 2030. Clim. Res. 13 (1999), 1–15.
101. [101] Clayton, T.C., Thompson, M., Meade, T.W., Recent respiratory infection and risk of cardiovascular disease: case–control study through a general practice database. Eur. Heart J. 29 (2008), 96–103, 10.1093/eurheartj/ehm516.
102. [102] Dong, M., et al. Cold exposure promotes atherosclerotic plaque growth and instability via UCP1-dependent lipolysis. Cell Metab. 18 (2013), 118–129, 10.1016/j.cmet.2013.06.003.
103. [103] Tian, X.Y., et al. Thermoneutral housing accelerates metabolic inflammation to potentiate atherosclerosis but not insulin resistance. Cell Metab. 23 (2016), 165–178, 10.1016/j.cmet.2015.10.003.
104. [104] Sacco, E., et al. Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence. Expert Opin. Drug Discovery 9 (2014), 433–448, 10.1517/17460441.2014.892923.
105. [105] Himms-Hagen, J., et al. Multilocular fat cells in WAT of CL-316243-treated rats derive directly from white adipocytes. Am. J. Physiol. Cell Physiol. 279 (2000), C670–C681.
106. [106] Weyer, C., Tataranni, P.A., Snitker, S., Danforth, E. Jr., Ravussin, E., Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes 47 (1998), 1555–1561.
107. [107] van Baak, M.A., et al. Acute effect of L-796568, a novel beta 3-adrenergic receptor agonist, on energy expenditure in obese men. Clin. Pharmacol. Ther. 71 (2002), 272–279, 10.1067/mcp.2002.122527.
108. [108] Larsen, T.M., et al. Effect of a 28-d treatment with L-796568, a novel beta(3)-adrenergic receptor agonist, on energy expenditure and body composition in obese men. Am. J. Clin. Nutr. 76 (2002), 780–788.
109. [109] Buemann, B., Toubro, S., Astrup, A., Effects of the two beta3-agonists, ZD7114 and ZD2079 on 24 hour energy expenditure and respiratory quotient in obese subjects. Int. J. Obes. Relat. Metab. Disord. 24 (2000), 1553–1560.
110. [110] Arch, J.R., Beta(3)-adrenoceptor agonists: potential, pitfalls and progress. Eur. J. Pharmacol. 440 (2002), 99–107.
111. [111] Arch, J.R., Challenges in beta(3)-adrenoceptor agonist drug development. Ther. Adv. Endocrinol. Metab. 2 (2011), 59–64, 10.1177/2042018811398517.
112. [112] Cypess, A.M., et al. Activation of human brown adipose tissue by a beta3-adrenergic receptor agonist. Cell Metab. 21 (2015), 33–38, 10.1016/j.cmet.2014.12.009.
113. [113] Marso, S.P., et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N. Engl. J. Med., 2016, 10.1056/NEJMoa1603827.
114. [114] Lockie, S.H., et al. Direct control of brown adipose tissue thermogenesis by central nervous system glucagon-like peptide-1 receptor signaling. Diabetes 61 (2012), 2753–2762, 10.2337/db11-1556.
115. [115] Kooijman, S., et al. Central GLP-1 receptor signalling accelerates plasma clearance of triacylglycerol and glucose by activating brown adipose tissue in mice. Diabetologia 58 (2015), 2637–2646, 10.1007/s00125-015-3727-0.
116. [116] Beiroa, D., et al. GLP-1 agonism stimulates brown adipose tissue thermogenesis and browning through hypothalamic AMPK. Diabetes 63 (2014), 3346–3358, 10.2337/db14-0302.
117. [117] Heppner, K.M., et al. Contribution of brown adipose tissue activity to the control of energy balance by GLP-1 receptor signalling in mice. Diabetologia 58 (2015), 2124–2132, 10.1007/s00125-015-3651-3.
118. [118] Wei, Q., Li, L., Chen, J.A., Wang, S.H., Sun, Z.L., Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity. Ann. Clin. Lab. Sci. 45 (2015), 158–165.
119. [119] Tomas, E., et al. GLP-1(32-36)amide Pentapeptide increases basal energy expenditure and inhibits weight gain in obese mice. Diabetes 64 (2015), 2409–2419, 10.2337/db14-1708.
120. [120] Xu, F., et al. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1. Diabetologia 59 (2016), 1059–1069, 10.1007/s00125-016-3896-5.
121. [121] Joyner, M.J., Green, D.J., Exercise protects the cardiovascular system: effects beyond traditional risk factors. J. Physiol. 587 (2009), 5551–5558, 10.1113/jphysiol.2009.179432.
122. [122] Haczeyni, F., et al. Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice. Obesity (Silver Spring) 23 (2015), 1845–1855, 10.1002/oby.21170.
123. [123] Disanzo, B.L., You, T., Effects of exercise training on indicators of adipose tissue angiogenesis and hypoxia in obese rats. Metabolism 63 (2014), 452–455, 10.1016/j.metabol.2013.12.004.
124. [124] Vieira, V.J., Valentine, R.J., Mitochondrial biogenesis in adipose tissue: can exercise make fat cells ‘fit’?. J. Physiol. 587 (2009), 3427–3428, 10.1113/jphysiol.2009.175307.
125. [125] Rao, R.R., et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell 157 (2014), 1279–1291, 10.1016/j.cell.2014.03.065.
126. [126] Bostrom, P., et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (2012), 463–468, 10.1038/nature10777.
127. [127] Giralt, M., Gavalda-Navarro, A., Villarroya, F., Fibroblast growth factor-21, energy balance and obesity. Mol. Cell. Endocrinol. 418:Pt 1 (2015), 66–73, 10.1016/j.mce.2015.09.018.
128. [128] Guo, Y., Liu, Q., Gui, Y., Liao, C., Xu, D., Exercise promotes cardiac-specific fibroblast growth factor 21 expression. Int. J. Cardiol. 203 (2016), 532–533, 10.1016/j.ijcard.2015.10.231.
129. [129] Planavila, A., Redondo-Angulo, I., Villarroya, F., FGF21 and cardiac physiopathology. Front. Endocrinol. (Lausanne), 6, 2015, 133, 10.3389/fendo.2015.00133.
130. [130] Albrecht, E., et al. Irisin — a myth rather than an exercise-inducible myokine. Sci. Rep., 5, 2015, 8889, 10.1038/srep08889.
131. [131] Jedrychowski, M.P., et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 22 (2015), 734–740, 10.1016/j.cmet.2015.08.001.
132. [132] Aydin, S., et al. Cardiac, skeletal muscle and serum irisin responses to with or without water exercise in young and old male rats: cardiac muscle produces more irisin than skeletal muscle. Peptides 52 (2014), 68–73, 10.1016/j.peptides.2013.11.024.
133. [133] Li, Z.Y., et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci. Ther. 20 (2014), 344–354, 10.1111/cns.12219.
134. [134] Palmer, B.F., Clegg, D.J., An emerging role of natriuretic peptides: igniting the fat furnace to fuel and warm the heart. Mayo Clin. Proc. 90 (2015), 1666–1678, 10.1016/j.mayocp.2015.08.006.
135. [135] Bordbar, S., Bigi, M.A., Aslani, A., Rahimi, E., Ahmadi, N., Effect of endurance and strength exercise on release of brain natriuretic peptide. J. Cardiovasc. Dis. Res. 3 (2012), 22–25, 10.4103/0975-3583.91599.
136. [136] Follenius, M., Brandenberger, G., Increase in atrial natriuretic peptide in response to physical exercise. Eur. J. Appl. Physiol. Occup. Physiol. 57 (1988), 159–162.
137. [137] Stanford, K.I., Middelbeek, R.J., Goodyear, L.J., Exercise effects on white adipose tissue: Beiging and metabolic adaptations. Diabetes 64 (2015), 2361–2368, 10.2337/db15-0227.
138. [138] Rothwell, N.J., Stock, M.J., A role for brown adipose tissue in diet-induced thermogenesis. Nature 281 (1979), 31–35, 10.1038/281031a0.
139. [139] Kozak, L.P., Brown fat and the myth of diet-induced thermogenesis. Cell Metab. 11 (2010), 263–267, 10.1016/j.cmet.2010.03.009.
140. [140] Webb, A.J., et al. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51 (2008), 784–790, 10.1161/hypertensionaha.107.103523.
141. [141] Siervo, M., Lara, J., Ogbonmwan, I., Mathers, J.C., Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J. Nutr. 143 (2013), 818–826, 10.3945/jn.112.170233.
142. [142] Velmurugan, S., et al. Antiplatelet effects of dietary nitrate in healthy volunteers: involvement of cGMP and influence of sex. Free Radic. Biol. Med. 65 (2013), 1521–1532, 10.1016/j.freeradbiomed.2013.06.031.
143. [143] Mitschke, M.M., et al. Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J. 27 (2013), 1621–1630, 10.1096/fj.12-221580.
144. [144] Haas, B., et al. Protein kinase G controls brown fat cell differentiation and mitochondrial biogenesis. Sci. Signal., 2, 2009, ra78, 10.1126/scisignal.2000511.
145. [145] Roberts, L.D., et al. Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway. Diabetes 64 (2015), 471–484, 10.2337/db14-0496.
146. [146] Lock, A.L., Bauman, D.E., Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 39 (2004), 1197–1206.
147. [147] Shokryzadan, P., et al. Conjugated linoleic acid: a potent fatty acid linked to animal and human health. Crit. Rev. Food Sci. Nutr., 2015, 10.1080/10408398.2015.1060190.
148. [148] Noone, E.J., Roche, H.M., Nugent, A.P., Gibney, M.J., The effect of dietary supplementation using isomeric blends of conjugated linoleic acid on lipid metabolism in healthy human subjects. Br. J. Nutr. 88 (2002), 243–252.
149. [149] Blankson, H., et al. Conjugated linoleic acid reduces body fat mass in overweight and obese humans. J. Nutr. 130 (2000), 2943–2948.
150. [150] Thom, E., Wadstein, J., Gudmundsen, O., Conjugated linoleic acid reduces body fat in healthy exercising humans. J. Int. Med. Res. 29 (2001), 392–396.
151. [151] Gaullier, J.-M., et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am. J. Clin. Nutr. 79 (2004), 1118–1125.
152. [152] Berven, G., et al. Safety of conjugated linoleic acid (CLA) in overweight or obese human volunteers. Eur. J. Lipid Sci. Technol. 102 (2000), 455–462.
153. [153] Zambell, K.L., et al. Conjugated linoleic acid supplementation in humans: effects on body composition and energy expenditure. Lipids 35 (2000), 777–782.
154. [154] House, R.L., et al. Functional genomic characterization of delipidation elicited by trans-10, cis-12-conjugated linoleic acid (t10c12-CLA) in a polygenic obese line of mice. Physiol. Genomics 21 (2005), 351–361.
155. [155] LaRosa, P.C., et al. trans-10, cis-12 conjugated linoleic acid causes inflammation and delipidation of white adipose tissue in mice: a microarray and histological analysis. Physiol. Genomics 27 (2006), 282–294.
156. [156] Shen, W., et al. Conjugated linoleic acid reduces adiposity and increases markers of browning and inflammation in white adipose tissue of mice. J. Lipid Res. 54 (2013), 909–922, 10.1194/jlr.M030924.
157. [157] West, D.B., Blohm, F.Y., Truett, A.A., DeLany, J.P., Conjugated linoleic acid persistently increases total energy expenditure in AKR/J mice without increasing uncoupling protein gene expression. J. Nutr. 130 (2000), 2471–2477.
158. [158] Woods, R., in: Proceedings of Tthe Physiological Society. 2016 (The Physiological Society).
159. [159] Ohnuki, K., Haramizu, S., Oki, K., Ishihara, K., Fushiki, T., A single oral administration of conjugated linoleic acid enhanced energy metabolism in mice. Lipids 36 (2001), 583–587.
160. [160] Bouillaud, F., Ricquier, D., Mory, G., Thibault, J., Increased level of mRNA for the uncoupling protein in brown adipose tissue of rats during thermogenesis induced by cold exposure or norepinephrine infusion. J. Biol. Chem. 259 (1984), 11583–11586.
161. [161] Marik, P.E., Varon, J., Omega-3 dietary supplements and the risk of cardiovascular events: a systematic review. Clin. Cardiol. 32 (2009), 365–372, 10.1002/clc.20604.
162. [162] Geleijnse, J.M., Giltay, E.J., Grobbee, D.E., Donders, A.R., Kok, F.J., Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J. Hypertens. 20 (2002), 1493–1499.
163. [163] Skilton, M.R., et al. Fetal growth, omega-3 (n − 3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The cardiovascular risk in young Finns study. Am. J. Clin. Nutr. 97 (2013), 58–65.
164. [164] Breslow, J., L. n − 3 fatty acids and cardiovascular disease. Am. J. Clin. Nutr. 83 (2006), 1477S–1482S.
165. [165] Kim, M., et al. Fish oil intake induces UCP1 upregulation in brown and white adipose tissue via the sympathetic nervous system. Sci. Rep., 5, 2015, 18013, 10.1038/srep18013.
166. [166] Janovska, P., Flachs, P., Kazdova, L., Kopecky, J., Anti-obesity effect of n − 3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis. Physiol. Res. 62 (2013), 153–161.
167. [167] Fleckenstein-Elsen, M., et al. Eicosapentaenoic acid and arachidonic acid differentially regulate adipogenesis, acquisition of a brite phenotype and mitochondrial function in primary human adipocytes. Mol. Nutr. Food Res., 2016, 10.1002/mnfr.201500892.
168. [168] Simopoulos, A.P., The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. (Maywood) 233 (2008), 674–688, 10.3181/0711-mr-311.
169. [169] Antoniades, C., et al. Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J. Am. Coll. Cardiol. 59 (2012), 60–70, 10.1016/j.jacc.2011.08.062.
170. [170] Antoniades, C., et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 124 (2011), 335–345, 10.1161/CIRCULATIONAHA.110.985150.
171. [171] Antoniades, C., et al. Induction of vascular GTP-cyclohydrolase I and endogenous tetrahydrobiopterin synthesis protect against inflammation-induced endothelial dysfunction in human atherosclerosis. Circulation 124 (2011), 1860–1870, 10.1161/CIRCULATIONAHA.111.029272.
172. [172] Antoniades, C., et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 122 (2010), S66–S73, 10.1161/CIRCULATIONAHA.109.927376.